Yangzhou Rixing Bio-Tech

Yangzhou Rixing Bio-Tech is a prominent Chinese biotechnology company specializing in the research, development, and large-scale production of chitin and chitosan derivatives. Established in 1992, the company has grown into one of the world's leading suppliers of Glucosamine and Chitosan, serving the pharmaceutical, nutraceutical, and food industries. Its core product portfolio includes Glucosamine Hydrochloride, Glucosamine Sulfate, and N-Acetyl-D-Glucosamine, which are widely utilized in the treatment of osteoarthritis and for general joint health. The company operates advanced manufacturing facilities in Yangzhou, Jiangsu Province, and maintains rigorous quality standards with certifications such as GMP, ISO, and HALAL. Rixing Bio-Tech is publicly traded on the National Equities Exchange and Quotations (NEEQ) in China. By leveraging its expertise in marine biological resources, the company provides essential raw materials to a global customer base across North America, Europe, and Asia.